Accéder au contenu
Merck

Targeting of human dendritic cells by autologous NK cells.

Journal of immunology (Baltimore, Md. : 1950) (1999-12-10)
J L Wilson, L C Heffler, J Charo, A Scheynius, M T Bejarano, H G Ljunggren
RÉSUMÉ

NK cells have the capacity to spontaneously kill tumor cell lines, in particular cell lines of hemopoietic origin. In contrast, they do not generally kill nontransformed autologous cells. However, here we demonstrate that short-term activated polyclonal human NK cells, as well as human NK cell lines, efficiently lyse autologous dendritic cells (DC) derived from peripheral blood monocytes as well as Langerhans-like cells derived from CD34+ stem cells isolated from umbilical cord blood. Lysis of autologous DC by short-term activated NK cells and NK cell lines was dependent on granule exocytosis, since total abrogation of lysis was observed in the presence of EGTA. Induction of DC maturation by LPS, monocyte conditioned media (MCM), or stimulation through CD40 ligand (CD40L) rendered the DC less susceptible to lysis by NK cells. Infection of DC with influenza virus was likewise associated with a reduced susceptibility to lysis by NK cells. Thus, susceptibility to lysis by autologous NK cells is a particular property of immature DC. The present results are discussed in relation to the ability of DC to interact with NK cells and to the ability of NK cells to regulate development of specific immunity.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Formaldéhyde solution, tested according to Ph. Eur.